Ac-, -NH₂, Nle and D-Phe: Reading the Modifications in a Peptide Name

Most research peptide names are written in a notation nobody explains. A sequence of three-letter codes is straightforward enough, but the material around it — a prefix, a suffix, a residue that is not one of the twenty, a letter D in front of an amino acid — carries real chemical information. Each element changes the molecule in a defined way, most of them change the mass by a number you can predict and check, and two of them cannot be seen on a mass spectrum at all.

Quick answer

What do Ac-, -NH₂, Aib, Nle and D- mean in a peptide name? Ac- is N-terminal acetylation, which adds 42.0106 Da. -NH₂ is C-terminal amidation, which removes 0.9840 Da by replacing a hydroxyl with an amine. Aib is α-aminoisobutyric acid and Nle is norleucine — residues that exist in the molecule but not in the standard twenty. D- marks a residue built with the mirror-image stereochemistry. All of these are deliberate design choices, usually made to resist enzymatic breakdown or to lock a conformation. Two of them are invisible to mass spectrometry: norleucine has exactly the same mass as leucine and isoleucine, and a D-residue has exactly the same mass as its L counterpart.

One worked example, read element by element

MT-2 is written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH₂, with a lactam bridge between Asp2 and Lys7. That single name carries five separate modifications, which makes it a useful place to start.

Read that way, the name is a specification rather than a label. Our overview of the sequence notation itself is in reading a peptide sequence, and the compound in context is covered in MT-2 and melanocortin receptor activity.

N-terminal acetylation: Ac-

A free peptide N-terminus carries a primary amine. Acetylation caps it with an acetyl group, converting NH₂ into NH-COCH₃. The net addition is C₂H₂O, a monoisotopic 42.0106 Da.

Two consequences follow. The positive charge that the free amine would carry at physiological pH is gone, which changes chromatographic behaviour and can change solubility. And the peptide becomes resistant to aminopeptidases, which cleave from the free N-terminus. Capping is one of the standard ways to extend a peptide's survival in a biological matrix.

C-terminal amidation: -NH₂

The counterpart at the other end. A free C-terminus is a carboxylic acid; amidation converts COOH into CONH₂. Because a hydroxyl is swapped for an amine, the mass goes down by 0.9840 Da.

That sub-dalton shift is worth knowing because it is easy to misread. A peptide one dalton lighter than you expected may be amidated rather than degraded — and conversely, deamidation of an asparagine shifts mass by roughly −1 Da in the same direction. On a low-resolution instrument the two can look similar. Our note on reading a mass spectrum covers resolution, and reconstituted stability covers the deamidation chemistry.

Amidation also removes the C-terminal negative charge and blocks carboxypeptidases, the mirror of what acetylation does at the N-terminus.

Residues outside the standard twenty

The norleucine substitution is a quietly elegant piece of design. Methionine is one of the most oxidation-prone residues; swapping it for norleucine keeps the size and hydrophobicity almost unchanged while removing the sulfur that oxidises. The cost is that norleucine is isobaric with leucine and isoleucine — all three are C₆H₁₁NO — so a mass measurement cannot tell them apart.

D-amino acids

Nineteen of the twenty standard amino acids are chiral, and ribosomal synthesis uses the L form exclusively. A D-residue is the mirror image. Chemically it is the same atoms in the same connectivity, so the mass is identical; what changes is the three-dimensional arrangement.

Deliberate D-substitution does two things. Proteases evolved to act on L-peptides generally cannot process a D-residue, so a single substitution at a cleavage site can substantially extend survival. And because the side chain now points elsewhere, the backbone is pushed into a different conformation, which is often the point rather than a side effect.

The critical analytical consequence: stereochemistry is invisible to mass spectrometry. A peptide with an unintended D-residue has exactly the mass it should have. This matters beyond notation, because D-residues can also arise accidentally during synthesis, and we treat that separately in racemisation and D-amino acid impurities.

Cyclisation

A lactam bridge joins a side-chain carboxyl to a side-chain amine — in MT-2, the aspartate at position 2 to the lysine at position 7. Forming the amide releases water, so the cyclic peptide is 18.0106 Da lighter than the linear precursor.

Cyclisation rigidifies the molecule and blocks exopeptidases at both ends. It has a further consequence worth noting: a side chain consumed by the bridge is no longer available for its usual chemistry. In MT-2 the bridged aspartate cannot form the succinimide intermediate that drives deamidation, because the side-chain carboxyl is already committed.

Disulfide bridges are the other common cyclisation and behave differently enough to need their own treatment — see disulfide bonds and oxidation state.

What a mass spectrum can and cannot settle

This is the general shape of the problem. Mass spectrometry is excellent at composition and poor at arrangement. Establishing arrangement needs orthogonal methods, which is why identity is a harder claim than purity. Our comparison of the two main techniques is in HPLC versus mass spectrometry.

Key takeaways

• Ac- adds 42.0106 Da and caps the N-terminal amine, blocking aminopeptidases.
• -NH₂ subtracts 0.9840 Da and blocks carboxypeptidases. The direction surprises people.
• Aib is a doubly methylated glycine that forces helical conformation and is hard to couple.
• Nle replaces methionine without the oxidisable sulfur, at the cost of being isobaric with Leu and Ile.
• A D-residue has exactly the same mass as its L form. Stereochemistry is invisible to MS.
• A lactam bridge costs 18.0106 Da and consumes the side chains it joins, which removes their other chemistry.
• Mass spectrometry establishes composition well and arrangement poorly.

Frequently asked questions

Does a modification mean the peptide is not the real compound?

No — in almost every case the modification is part of the compound's definition. MT-2 is not an acetylated version of something else; the acetyl group, the norleucine, the D-phenylalanine and the amide are all part of what MT-2 is. A name without them would be describing a different molecule.

Why is the amidation mass change negative?

Because it is a substitution, not an addition. The hydroxyl of the carboxylic acid (17.0027 Da) is replaced by an amine group (16.0187 Da), and the amine is lighter by 0.9840 Da.

Can I tell from the certificate whether the peptide is amidated?

The sequence as written should state it, and the observed mass should match the amidated calculation rather than the free-acid one. If the stated sequence carries -NH₂ and the reported mass matches the free acid, that is a real discrepancy worth raising. Our certificate glossary covers the fields.

Are D-amino acids a sign of poor synthesis?

It depends entirely on whether they were intended. A D-residue written into the sequence is a design feature. A D-residue that appears where an L was specified is a synthesis defect, and because it is invisible to MS it needs a dedicated method to detect.

Why use norleucine instead of methionine?

To remove an oxidation liability. Methionine oxidises readily to the sulfoxide, adding 16 Da and creating a degradation product. Norleucine is a close steric match with no sulfur, so that route simply does not exist.

Sources

• Subirós-Funosas R, El-Faham A, Albericio F. PyOxP and PyOxB: the Oxyma-based novel family of phosphonium salts. Org Biomol Chem. 2010;8(16):3665–73. DOI
• Hu L, Zhao J. Ynamide coupling reagents: origin and advances. Acc Chem Res. 2024;57(6):855–869. DOI

Journal citations retrieved via PubMed. Monoisotopic mass values are calculated from standard atomic masses.

This article describes chemical notation and analytical chemistry only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.